Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Curcuma, most commonly referring to Curcuma longa (turmeric), has been studied for its potential effects on endometriosis, primarily due to its active constituent curcumin. While turmeric has a long history of use in traditional medicine for inflammatory and gynecological conditions, its application for endometriosis has gained some scientific interest in recent years. Preclinical studies—mainly in animal models and cell cultures—have demonstrated that curcumin possesses anti-inflammatory, anti-proliferative, and anti-angiogenic properties. These effects may be relevant to endometriosis, a condition characterized by inflammation, abnormal tissue growth, and new blood vessel formation.

For example, in vitro studies have shown that curcumin can suppress the proliferation of endometrial cells and reduce the expression of inflammatory cytokines. Animal studies have indicated that curcumin may decrease lesion size and modulate immune responses in induced models of endometriosis. However, robust clinical trials in humans are lacking, and evidence from human studies is extremely limited. As a result, while there is a plausible scientific rationale and some supporting preclinical evidence, the overall quality and quantity of evidence do not allow for strong recommendations for its use in endometriosis at this time. Most guidelines and medical organizations do not endorse curcumin as a standard treatment for endometriosis, and its use should be considered experimental pending further research.

More about Curcuma
More about Endometriosis

Other ingredients used for Endometriosis

Other health conditions supported by Curcuma

Products containing Curcuma